Circulating osteogenic cells: Implications for injury, repair, and regeneration

Journal of Bone and Mineral Research

Volumn 26, Issue 8, 2011, Pages 1685-1693

  Pignolo, Robert J ^a   Kassem, Moustapha ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

blood; circulating osteogenic precursor cells; fracture; heterotopic ossification; mesenchymal stem cells

Indexed keywords

BONE INJURY; BONE REGENERATION; BONE REMODELING; CELL ISOLATION; CELL MIGRATION; HUMAN; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOBLAST; PATHOPHYSIOLOGY; REVIEW; STEM CELL;

ANIMALS; CELL MOVEMENT; HUMANS; OSTEOBLASTS; OSTEOGENESIS; REGENERATION; STEM CELLS; WOUND HEALING;

EID: 79960631998     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.370     Document Type: Review

References (90)

1. Sacchetti B, Funari A, Michienzi S, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell. 2007; 131: 324-336. (Pubitemid 47592917)
2. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8: 315-317. (Pubitemid 44269669)
3. Gronthos S, Graves SE, Ohta S, Simmons PJ,. The STRO-1+ fraction of adult human bone marrow contains the osteogenic precursors. Blood. 1994; 84: 4164-4173. (Pubitemid 24371919)
4. Bentzon JF, Stenderup K, Hansen FD, et al. Tissue distribution and engraftment of human mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene. Biochem Biophys Res Commun. 2005; 330: 633-640. (Pubitemid 40462134)
5. Bianco P, Robey PG, Simmons PJ,. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008; 2: 313-319. (Pubitemid 351467394)
6. Hauge EM, Qvesel D, Eriksen EF, Mosekilde L, Melsen F,. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res. 2001; 16: 1575-1582. (Pubitemid 32786425)
7. Kumagai K, Vasanji A, Drazba JA, Butler RS, Muschler GF,. Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res. 2008; 26: 165-175. (Pubitemid 351220134)
8. Boban I, Barisic-Dujmovic T, Clark SH,. Parabiosis model does not show presence of circulating osteoprogenitor cells. Genesis. 2010; 48: 171-182.
9. Olmsted-Davis EA, Gugala Z, Camargo F, et al. Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc Natl Acad Sci USA. 2003; 100: 15877-15882. (Pubitemid 38021083)
10. Dominici M, Pritchard C, Garlits JE, Hofmann TJ, Persons DA, Horwitz EM,. Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc Natl Acad Sci USA. 2004; 101: 11761-11766. (Pubitemid 39095369)
11. Hayakawa J, Migita M, Ueda T, Shimada T, Fukunaga Y,. Generation of a chimeric mouse reconstituted with green fluorescent protein-positive bone marrow cells: a useful model for studying the behavior of bone marrow cells in regeneration in vivo. Int J Hematol. 2003; 77: 456-462. (Pubitemid 36828308)
12. Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y,. Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Biochem Biophys Res Commun. 2007; 354: 453-458. (Pubitemid 46161345)
13. Otsuru S, Tamai K, Yamazaki T, Yoshikawa H, Kaneda Y,. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by CXCR4/SDF-1 pathway. Stem Cells. 2008; 26: 223-234.
14. Koc ON, Peters C, Aubourg P, et al. Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. Exp Hematol. 1999; 27: 1675-1681. (Pubitemid 29526752)
15. Horwitz EM, Gordon PL, Koo WK, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA. 2002; 99: 8932-8937. (Pubitemid 34693661)
16. Suda RK, Billings PC, Egan KP, et al. Circulating osteogenic precursor cells in heterotopic bone formation. Stem Cells. 2009; 27: 2209-2219.
17. Hong HS, Lee J, Lee E, et al. A new role of substance P as an injury-inducible messenger for mobilization of CD29(+) stromal-like cells. Nat Med. 2009; 15: 425-435.
18. Pitchford SC, Furze RC, Jones CP, Wengner AM, Rankin SM,. Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell. 2009; 4: 62-72.
19. Sackstein R, Merzaban JS, Cain DW, et al. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med. 2008; 14: 181-187. (Pubitemid 351214550)
20. Tondreau T, Meuleman N, Delforge A, et al. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells. 2005; 23: 1105-1112. (Pubitemid 41377726)
21. Kuznetsov SA, Friedenstein AJ, Robey PG,. Factors required for bone marrow stromal fibroblast colony formation in vitro. Br J Haematol. 1997; 97: 561-570. (Pubitemid 27261620)
22. Kuznetsov SA, Mankani MH, Leet AI, Ziran N, Gronthos S, Robey PG,. Circulating connective tissue precursors: extreme rarity in humans and chondrogenic potential in guinea pigs. Stem Cells. 2007; 25: 1830-1839. (Pubitemid 47121863)
23. Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, Robey PG,. Circulating skeletal stem cells. J Cell Biol. 2001; 153: 1133-1140.
24. Zvaifler NJ, Marinova-Mutafchieva L, Adams G, et al. Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res. 2000; 2: 477-488. (Pubitemid 32223796)
25. Rochefort GY, Delorme B, Lopez A, et al. Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells. 2006; 24: 2202-2208. (Pubitemid 44527473)
26. Rosada C, Justesen J, Melsvik D, Ebbesen P, Kassem M,. The human umbilical cord blood: a potential source for osteoblast progenitor cells. Calcified Tissue International. 2003; 72: 135-142. (Pubitemid 36919533)
27. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K,. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006; 24: 1294-1301. (Pubitemid 44464698)
28. Long MW, Williams JL, Mann KG,. Expression of human bone-related proteins in the hematopoietic microenvironment. J Clin Invest. 1990; 86: 1387-1395. (Pubitemid 20372581)
29. Long MW, Robinson JA, Ashcraft EA, Mann KG,. Regulation of human bone marrow-derived osteoprogenitor cells by osteogenic growth factors. J Clin Invest. 1995; 95: 881-887.
30. Eghbali-Fatourechi GZ, Lamsam J, Fraser D, Nagel D, Riggs BL, Khosla S,. Circulating osteoblast-lineage cells in humans. N Engl J Med. 2005; 352: 1959-1966. (Pubitemid 40638366)
31. Eghbali-Fatourechi GZ, Modder UI, Charatcharoenwitthaya N, et al. Characterization of circulating osteoblast lineage cells in humans. Bone. 2007; 40: 1370-1377. (Pubitemid 46550982)
32. Minasi MG, Riminucci M, De Angelis L, et al. The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development. 2002; 129: 2773-2783. (Pubitemid 34874259)
33. Cossu G, Bianco P,. Mesoangioblasts-vascular progenitors for extravascular mesodermal tissues. Curr Opin Genet Dev. 2003; 13: 537-542. (Pubitemid 37204932)
34. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM,. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest. 2002; 109: 337-346. (Pubitemid 34141807)
35. Qi H, Aguiar DJ, Williams SM, La Pean A, Pan W, Verfaillie CM,. Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells. Proc Natl Acad Sci USA. 2003; 100: 3305-3310. (Pubitemid 36356578)
36. Rozen N, Bick T, Bajayo A, et al. Transplanted blood-derived endothelial progenitor cells (EPC) enhance bridging of sheep tibia critical size defects. Bone. 2009; 45: 918-924.
37. Lounev VY, Ramachandran R, Wosczyna MN, et al. Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am. 2009; 91: 652-663.
38. Kaplan FS, Glaser DL, Shore EM, et al. Hematopoietic stem-cell contribution to ectopic skeletogenesis. J Bone Joint Surg Am. 2007; 89-A: 347-357. (Pubitemid 46214354)
39. Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, Olsen BR,. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med. 2010; 16: 1400-1406.
40. Matsumoto T, Kawamoto A, Kuroda R, et al. Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing. Am J Pathol. 2006; 169: 1440-1457. (Pubitemid 351194376)
41. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A,. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med. 1994; 1: 71-81.
42. Choi YH, Burdick MD, Strieter RM,. Human circulating fibrocytes have the capacity to differentiate osteoblasts and chondrocytes. Int J Biochem Cell Biol. 2010; 42: 662-671.
43. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN,. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol. 2001; 166: 7556-7562. (Pubitemid 32525636)
44. Chesney J, Metz C, Stavitsky AB, Bacher M, Bucala R,. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol. 1998; 160: 419-425. (Pubitemid 28116757)
45. Chesney J, Bacher M, Bender A, Bucala R,. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci USA. 1997; 94: 6307-6312. (Pubitemid 27270680)
46. Quan TE, Cowper S, Sou-Pan W, Bockenstedt LK, Bucala R,. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol. 2004; 36: 598-606. (Pubitemid 38316817)
47. Metz CN,. Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci. 2003; 60: 1342-1350. (Pubitemid 36900518)
48. Yang L, Scott PG, Giuffre J, Shankowsky HA, Ghahary A, Tredget EE,. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest. 2002; 82: 1183-1192. (Pubitemid 35014852)
49. Phillips RJ, Burdick MD, Hong K, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest. 2004; 114: 438-446. (Pubitemid 39071616)
50. Bellini A, Mattoli S,. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest. 2007; 87: 858-870. (Pubitemid 47267815)
51. Kuwana M, Okazaki Y, Kodama H, et al. Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol. 2003; 74: 833-845. (Pubitemid 38040360)
52. Zhao Y, Glesne D, Huberman E,. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA. 2003; 100: 2426-2431. (Pubitemid 36297515)
53. Ratajczak MZ, Kucia M, Reca R, Majka M, Janowska-Wieczorek A, Ratajczak J,. Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells "hide out" in the bone marrow. Leukemia. 2004; 18: 29-40. (Pubitemid 38159436)
54. Strieter RM, Keeley EC, Burdick MD, Mehrad B,. The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis. Trans Am Clin Climatol Assoc. 2009; 120: 49-59.
55. Shafer J, Davis AR, Gannon FH, et al. Oxygen tension directs chondrogenic differentiation of myelo-monocytic progenitors during endochondral bone formation. Tissue Eng. 2007; 13: 2011-2019. (Pubitemid 47293997)
56. Ardianto B, Sugimoto T, Kawano S, et al. The HPB-AML-I cell line possesses the properties of mesenchymal stem cells. J Exp Clin Cancer Res. 2010; 29: 163.
57. Doehring LC, Heeger C, Aherrahrou Z, et al. Myeloid CD34+CD13+ precursor cells transdifferentiate into chondrocyte-like cells in atherosclerotic intimal calcification. Am J Pathol. 2010; 177: 473-480.
58. Alm JJ, Koivu HM, Heino TJ, Hentunen TA, Laitinen S, Aro HT,. Circulating plastic adherent mesenchymal stem cells in aged hip fracture patients. J Orthop Res. 2010; 28: 1634-1642.
59. Granero-Molto F, Weis JA, Miga MI, et al. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells. 2009; 27: 1887-1898.
60. Oe K, Miwa M, Sakai Y, Lee SY, Kuroda R, Kurosaka M,. An in vitro study demonstrating that haematomas found at the site of human fractures contain progenitor cells with multilineage capacity. J Bone Joint Surg Br. 2007; 89: 133-138. (Pubitemid 46218428)
61. Chan ED, Morales DV, Welsh CH, McDermott MT, Schwarz MI,. Calcium deposition with or without bone formation in the lung. Am J Respirat Crit Care Med. 2002; 165: 1654-1669. (Pubitemid 34693947)
62. Egan KP, Pignolo RJ,. COP cells in periarticular non-hereditary heterotopic ossification. J Bone Miner Res. 25: S1.
63. Egan KP, Pignolo RJ,. Circulating osteogenic cells in end-stage aortic valvular disease. Bone. 2010; 47: S233.
64. Mohler ER 3rd., Mechanisms of aortic valve calcification. Am J Cardiol. 2004; 94: 1396-1402, A6. (Pubitemid 39556209)
65. Demer LL, Tintut Y,. Vascular calcification: pathobiology of a multifaceted disease. Circulation. 2008; 117: 2938-2948. (Pubitemid 351787058)
66. Canfield AE, Sutton AB, Hoyland JA, Schor AM,. Association of thrombospondin-1 with osteogenic differentiation of retinal pericytes in vitro. J Cell Sci. 1996; 109 (pt 2): 343-353. (Pubitemid 26057117)
67. Proudfoot D, Skepper JN, Shanahan CM, Weissberg PL,. Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression. Arterioscler Thromb Vasc Biol. 1998; 18: 379-388. (Pubitemid 28125632)
68. Campbell GR, Campbell JH,. Vascular smooth muscle and arterial calcification. Z Kardiol. 2000; 89 (suppl 2): 54-62.
69. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL,. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest. 1993; 91: 1800-1809. (Pubitemid 23127387)
70. Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS,. Bone formation and inflammation in cardiac valves. Circulation. 2001; 103: 1522-1528. (Pubitemid 32226259)
71. Hunt JL, Fairman R, Mitchell ME, et al. Bone formation in carotid plaques: a clinicopathological study. Stroke. 2002; 33: 1214-1219. (Pubitemid 34517038)
72. Gossl M, Modder UI, Atkinson EJ, Lerman A, Khosla S,. Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol. 2008; 52: 1314-1325.
73. Pal SN, Rush C, Parr A, Van Campenhout A, Golledge J,. Osteocalcin positive mononuclear cells are associated with the severity of aortic calcification. Atherosclerosis. 2010; 210: 88-93.
74. McGonagle D, Gibbon W, O'Connor P, et al. A preliminary study of ultrasound aspiration of bone erosion in early rheumatoid arthritis. Rheumatology. 1999; 38: 329-331. (Pubitemid 29507182)
75. Rubin MR, Manavalan JS, Dempster DW, et al. Parathyroid hormone stimulates circulating osteogenic cells in hypoparathyroidism. J Clin Endocrinol Metab. 2011; 96: 176-186.
76. Dalle Carbonare L, Valenti MT, Zanatta M, Donatelli L, Lo Cascio V,. Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. Arthritis Rheum. 2009; 60: 3356-3365.
77. Undale A, Srinivasan B, Drake M, et al. Circulating osteogenic cells: characterization and relationship to rates of bone loss in postmenopausal women. Bone. 2010; 47: 83-92.
78. Zhu Q, Shu L, Yan J, Karaplis AC, Goltzman D, Miao D,. Endogenous PTH contributes to bone regeneration, formation and remodeling by stimulating osteoprogenitor cell recruitment following marrow ablation. J Bone Miner Res. 2010; 25: S1.
79. Falla N, Van Vlasselaer, Bierkens J, Borremans B, Schoeters G, Van Gorp U,. Characterization of a 5-fluorouracil-enriched osteoprogenitor population of the murine bone marrow. Blood. 1993; 82: 3580-3591. (Pubitemid 24006038)
80. Canalis E,. The fate of circulating osteoblasts. N Engl J Med. 2005; 352: 2014-2016. (Pubitemid 40638373)
81. Kan L, Liu Y, McGuire TL, et al. Dysregulation of local stem/progenitor cells as a common cellular mechanism for heterotopic ossification. Stem Cells. 2009; 27: 150-156.
82. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004; 10: 858-864. (Pubitemid 39070860)
83. Du R, Lu KV, Petritsch C, et al. HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell. 2008; 13: 206-220. (Pubitemid 351318372)
84. Cunningham NS, Paralkar V, Reddi AH,. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc Natl Acad Sci USA. 1992; 89: 11740-11744. (Pubitemid 23004719)
85. Olmsted-Davis E, Gannon FH, Ozen M, et al. Hypoxic adipocytes pattern early heterotopic bone formation. Am J Pathol. 2007; 170: 620-632. (Pubitemid 47339399)
86. Gelmini S, Mangoni M, Serio M, Romagnani P, Lazzeri E,. The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis. J Endocrinol Invest. 2008; 31: 809-819.
87. Schober A,. Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol. 2008; 28: 1950-1959.
88. Hoenig MR, Bianchi C, Sellke FW,. Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis. Curr Drug Targets. 2008; 9: 422-435. (Pubitemid 352025218)
89. Ratajczak MZ, Zuba-Surma E, Kucia M, Reca R, Wojakowski W, Ratajczak J,. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia. 2006; 20: 1915-1924. (Pubitemid 44614878)
90. Dar A, Kollet O, Lapidot T,. Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol. 2006; 34: 967-975. (Pubitemid 44080383)